Education
About Us
Working with TipRanks
Follow Us
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 957.80M | $ 726.44M | $ 517.24M | $ 484.14M | $ 441.75M |
| Gross Profit | $ 875.96M | $ 680.71M | $ 507.07M | $ 465.00M | $ 421.20M |
| Operating Income | $ 230.79M | $ -73.38M | $ -223.60M | $ -170.44M | $ -286.59M |
| EBITDA | $ 100.16M | $ -67.83M | $ -221.57M | $ -167.09M | $ -286.59M |
| Net Income | $ 226.45M | $ -61.29M | $ -215.97M | $ -167.87M | $ -281.58M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 755.99M | $ 438.87M | $ 416.82M | $ 520.71M | $ 631.96M |
| Total Assets | $ 1.19B | $ 748.96M | $ 587.81M | $ 700.12M | $ 782.62M |
| Total Debt | $ 51.99M | $ 57.20M | $ 62.00M | $ 56.13M | $ 44.46M |
| Net Debt | $ -267.59M | $ -131.45M | $ -52.85M | $ -91.31M | $ -281.57M |
| Total Liabilities | $ 454.96M | $ 317.20M | $ 187.40M | $ 159.23M | $ 155.61M |
| Stockholders' Equity | $ 732.79M | $ 431.75M | $ 400.41M | $ 540.89M | $ 627.01M |
| Cash Flow | |||||
| Free Cash Flow | $ 157.20M | $ -23.35M | $ -114.03M | $ -126.78M | $ -143.75M |
| Operating Cash Flow | $ 157.72M | $ 16.70M | $ -114.03M | $ -125.66M | $ -136.17M |
| Investing Cash Flow | $ -30.54M | $ 32.00M | $ 73.24M | $ -71.10M | $ 192.51M |
| Financing Cash Flow | $ 6.84M | $ 25.13M | $ 8.20M | $ 18.16M | $ 81.00M |